chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hello, I'm 31 years old. I would like to report some side effects that are not listed anywhere yet and I believe that people should know what to expect in case they decide to have this vaccine administered. Please pay close attention to what happened on the 3rd day. SHINGRIX->Date of administration: 04/20/18 Location of the pharmacy where the shot was administered: Pharmacy. My doctor recommended this vaccine because I had several shingles outbursts during a 1 year period. Side effects: 1st Day: Didn't sleep throughout the whole night, tossing and turning, unable to rest on my left side at all 2nd day: Very painful, injection site swollen, sore and red. On a scale from 1 to 10, it was 9. I woke up crying because of the pain. Joint pain overall tiredness dizziness lethargy sleepiness symptoms started to alleviate after I took 400mg of ibuprofens x2 times I drank more than 3 quarts of liquids (water and herbal tea). I went to sleep at 00:30AM 3rd day I woke up at 10:00 AM unable to open my left eye, it felt very dry, no discharge of any kind. I washed my face with cold water, warm water, wiped my eye with a special eyelid wipe. I put eye drops. My eye didn't open until 40 minutes later. I put a cold ice pack on it, later I put a warm one which seemed to do its job. I was able to open my eyes although both of them felt dry, but the left one significantly dryer. I managed to keep them open until 2:30 pm when I decided to lay outside because I felt the pain that I had in the morning it's coming back. I slept for 1.5h and I felt better when I woke up. My eyes are still sensitive, especially the left one. 4th day-> I slept all night, the side effects are almost gone, the injection site is still red and sore, but otherwise I am able to do my daily activities.
Hives on hands, shoulders, legs, arms, waist and face aproximately 2 hours after injection.  Treated with benadryl.
Patient fainted after Gardasil, and subsequently had seizure-like tonic reactions in both arms. Mom states that child had had similar seizure-like activity at age 7. No known reason for that seizure activity, although MD told her that she probably "needed glasses". No further follow-up was suggested at that time. Patient awoke easily (within 1 minute) after today's seizure like activity with the aid of ammonium salts. She was aware of her surroundings. BP immediately after event was 98/70, and subsequently rose to a normal 104/78. She was observed for 15 minutes after the event, and no adverse events were noted during the observation.
Patient was 20 wk gestation with twins @ date of vaccination. Physician had ordered flu vaccination. Patient miscarried twins @ 24 wks. 10-24-2010
slight headache; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 48 (unit unknown) female patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "slight headache". Patient stated she had no problems other than a slight headache.  No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-2021354545 same patient, drug(different dose), different event
shingles, still get them, got both vaccines/ Suspected vaccination failure; shingles, still get them; hip surgery; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and hip surgery. On an unknown date, the outcome of the vaccination failure, shingles and hip surgery were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and hip surgery to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 31-Oct-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient got both vaccines for shingles and they had not helped him.  The patient still got them.  The patient had a terrible case of shingles after his hip surgery.  Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding the completion of primary vaccination schedule, time to onset and laboratory test confirmation were unknown at the time of reporting. The follow-up could not be possible as no contact detail were available. This case was linked with case US2022AMR140020, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR140020:Same reporter
Two weeks after the vaccine, transient numbness, tingling experienced in left leg, right foot and leg, bilateral hands and arms, neck that comes and goes, and abnormal sensations of shooting, lightening-strike type feelings down right arm and right face.  Continual,constant and current feeling of numbness and tingling in right foot and toes, transient aching in toes and right ankle.  Elevated CCP that continues to climb.  Rheumatologist diagnosed autoimmune neuropathy; impending rheumatoid arthritis 2/4/22. Started methotrexate 15mg weekly and folic acid 1000mg daily on 2/5/22.
Became diaphoretic and lost consciousness after vaccine, was unresponsive for approx. one minute. Checked pulse and opened airway with Jaw lift.
pt recv vax & lt deltoid became swollen, tender, painful, red;rx keflex, redness gone 10 day, still sl swollen;
16APR96 1/2hr p/vax pt c/o tingling lips & itchy neck;phone call to clinic was told to to to MD immed;MD visit same day-no tx;17APR96 c/o feeling funny & swollen neck;to ER dx inc BP & swollen glands-hosp overnoc;MD stated probably not vax;
Incorrect product storage; No adverse effects reported; This spontaneous report as received from a registered nurse referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, allergies or concomitant medications.  On unknown date, the patient was vaccinated with improperly stored Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) for prophylaxis (which had a lot number R027322 and expiration date on 09-JUL-2021; however, dose, frequency and route of administration were not reported). The administered dose of the vaccine experienced a temperature excursion of 33.6 F for 24 hours and 30 minutes, as recorded by data logger. The vaccine had not had any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved.; Sender's Comments:  US-009507513-1904USA012028: US-009507513-1904USA012027:
This spontaneous report was received from a registered nurse, concerning multiple unspecified patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses GARDASIL 9 with lot # reported as N019523 and expiration date on 28-APR-2019 (strength, dose, route of administration or anatomical location were not reported), administered for prophylaxis. The storage temperature was 9 to 25 degrees Celsius (°C) (9.8 °C), for a timeframe of 20 minutes and 9 to 25 °C (8.5 °C) for 7 minutes. There was previous temperature excursion at 9 to 25 °C for 3.31 hours. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA015078: US-009507513-1709USA015077.
at 4am started with severe shaking chills, severe nausea that worsened until around 8am (temperature was measured at 97.7 degrees F).  at 8am had vomiting x 4 episodes over the next 20-30 minutes.  chills and nausea continued.  at 10:30am changed to feeling warm concern for fever - temperature measured at 100.2 degrees F, sweating, malaise and severe fatigue.  Took 1gm oral acetaminophen at around 10:45/11am and fever-ish feelings resolved around 2pm.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 30-Jun-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On an unknown date, post vaccination, the patient reported that she experienced symptoms of exposure during pregnancy.   No concomitant medication was reported.  Treatment information was unknown.  she was 26 weeks and 6 days pregnant when she received the vaccine.
Strep throat; Swollen tonsils; Extreme pain; This is a spontaneous report from a contactable other healthcare professional, the patient. A 32-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown, Expiry date: unknown, at the age of 32-year-old), via an unspecified route of administration, administered in left arm on 20Mar2021 15:30 as dose 1, single for covid-19 immunisation. Medical history included fibroids. The patient was allergic to latex. It was unknown if the patient was pregnant. Concomitant medications included montelukast sodium (SINGULAIR), amlodipine, sertraline, aripiprazole (ABILIFY). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19. On 22Mar2021 08:00, the patient experienced strep throat, swollen tonsils, extreme pain. The patient received amoxicillin as a therapeutic measure for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent nasal swab test twice on 23Mar2021 and the results were negative and pending. The outcome of events was not recovered.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Lymphadenopathy started within five hours of the vaccine, pain started within two hours of the injection. Lymph node was 1 inch by 2 inch in the office but got larger than this before it got smaller.   Large area of redness at the site of the injection.  He was better within four to six days of the vaccine.
Fever- 103, vomiting,  nausea, dizziness, body aches,  chills, headache
Spiking hot fevers, only controlled with alternating fever reducer every three hours. Rash on forehead and legs.
Trigeminal neuropathy; Headache.; This is a spontaneous report from a contactable consumer or other non hcp (patient himself) via a sponsored program.  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration in left arm on 14Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history includes covid was in hospital for a month and trigeminal neuropathy from unknown start and stop dates. The concomitant medications were not reported. The patient experienced trigeminal neuropathy, constant headache on an unspecified date in 2021. He reported that he thinks the first dose triggered his condition, trigeminal neuropathy and the vaccine was administered on his left arm where his condition is most prominent. With this, he wants to know if it is still safe for him to receive the second dose. The clinical outcome of all events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient reports feeling faint and passing outside.  4/17/2021 low energy and fatigue
I couldn't feel my lips very well for the first 12 hours. I felt confused for the first 8-10 hours, but was able to complete basic tasks. I had a sore arm for 3 days. I felt achy for the first 24 hours. I felt heavy and "awful" for 7 days and stayed in bed. This was my first dose of the vaccine.
I had upper body aches and heart palpitations. This lasted about a month.  I went to a walk-in clinic and they told me that they have seen the same reactions in Covid shots in other individuals . My  AST and ALT levels were elevated.  The  PVC lasted about a month and upper body aches lasted about a week.
The patient received the vaccine on January 20, 2021 uneventfully.  She did not develop soreness at the site.  Approximately 3 days later, she noted a bump that was sore to touch and slightly itchy.  It slowly got better.  She did apply clobetasol ointment on January 24 and 25.  It seemed better.  On January 28 the evening and 8 noticed some redness.  She saw me, her doctor, on January 29.  She had a 7 x 7 cm round pink area that was slightly warm and minimally tender.  This was at the site of injection.  It was slightly swollen. I did not give her the vaccine.  She got it through the health Department.
PATIENT REFERS THAT AFTER 5 MINUTES OF VACCINATION SHE STARTED FEELING HER HEART BEAT FAST. MILD TACHICHARDYA.
Patient presents from the nursing home with covid positive and shortness of breath. He was admitted for further evaluation and treated with remdesivir.
Report 2001028659-1 describes dizziness in an 18-year-old female who received hepatitis B vaccine recombinant (Engerix-B). The pt had a seizure disorder and received carbamazepine (Tegretol). On 12/03/2001, the pt received her 1st injection of Engerix-B. Post-vaccination, on 12/03/2001, the pt experienced dizziness. As of 12/03/2001, the outcome of the event was unknown.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLOOD PRESSURE FLUCTUATION (non-serious) with onset 2021, outcome "not recovered", described as "BP swings"; FATIGUE (non-serious) with onset 2021, outcome "not recovered"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "not recovered", described as "brain fog"; DIZZINESS (non-serious) with onset 2021, outcome "not recovered", described as "light-headedness/dizziness"; PARAESTHESIA (non-serious) with onset 2021, outcome "not recovered"; TINNITUS (non-serious) with onset 2021, outcome "not recovered". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Clinical course: Since receiving the vaccine a year ago, patient has been suffering "long COVID" like symptoms: BP swings, light-headedness/dizziness, tinnitus, Paranesthesia, fatigue and brain fog. Patient reported that a brief internet search seemed to indicate that they were not the only one. Patient was querying if remedies for such side effects were pursued of if some was already available. Patient reported that this condition was quite debilitating.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Infant was given combination vaccine of DTaP and IPV rather than each vaccine individually. There was no adverse reaction.
2/13/09 stabbing head pain, 2/14/09 chest pressure, 2/15/09 back and neck pain, 2/16/09 all of above. 2/18/09 diagnosed with costiocondritis.
Numbness in right Side of Face; Nausea; Dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), DIZZINESS (Dizziness), HEADACHE (Headache) and HYPOAESTHESIA (Numbness in right Side of Face) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced NAUSEA (Nausea), DIZZINESS (Dizziness) and HEADACHE (Headache). On 06-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in right Side of Face). At the time of the report, NAUSEA (Nausea), DIZZINESS (Dizziness), HEADACHE (Headache) and HYPOAESTHESIA (Numbness in right Side of Face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient requested 2nd dose of Pfizer.  When entering into NDiis it was caught that patient received Moderna as her first dose.  Patient received 2 different mrna vaccines
my tinnitus has gotten worse; I have higher blood pressure; continuous headaches; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (my tinnitus has gotten worse), BLOOD PRESSURE INCREASED (I have higher blood pressure) and HEADACHE (continuous headaches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced TINNITUS (my tinnitus has gotten worse), BLOOD PRESSURE INCREASED (I have higher blood pressure) and HEADACHE (continuous headaches). At the time of the report, TINNITUS (my tinnitus has gotten worse), BLOOD PRESSURE INCREASED (I have higher blood pressure) and HEADACHE (continuous headaches) had resolved. Not Provided          Reporter did not allow further contact
Diffuse papular/plaque dermatitis including involvement of the oral mucosa, tongue, lips, and throat starting 3 days after vaccination and lasting up to 2 weeks prior to improvement after systemic corticosteroids.
Patient received dose 1 of Moderna vaccine on 5/8/2021 and had witnessed seizure 5/12/2021- (first time ever). He was admitted to ICU on 5/12/2021 and discharged 5/15/2021. He states he had one seizure while in the ICU and another seizure 5/16/2021- at home after discharge. He has since been placed on anti-seizure medications and is scheduled for follow up with neurology on 6/2/2021. Patient's mother states ICU doctors told her they found a blood clot in the brain picked up by MRI.
The night of the 9th, I had injection site pain. That lasted for three days, at least. Significant pain but it didn't stop  me from work. It wasn't consistent pain - I was having trouble getting my arm up. Thursday, - 18th - I suddenly felt tired and feverish. I did a PCR test on the evening of the 18th. Then there was fever between 98.9 - 100.4. I had cough and sore throat and I had runny nose. The fever kind of subsided after I took Tylenol on the 18th and then again 19th and 20th, as well. My COVID result was negative. I made an emergency report on the 19th with my doctor. I had a virtual appt with her. She was under the opinion that it was a bacterial infection or allergic reaction. When I took - Levocedrizine - my runny nose symptoms got a little better. On 19th, she prescribed me Erythromycin - I took the full course. of that and my fever left the Sunday after I started that. I finished the full course of it by Tuesday. I still had a cough but I did not have any other symptoms after the course of medication (five days- I took two the first day and then one of the next four days after that) was finished. Note: I use CPAP at night. My cough took some time to subside - it probably subsided by the 26th.
Father reports pt. c/o headache approx. 5-6 pm on 12-11-12 that worsened when standing. Declined TYLENOL but symptoms persist, causing pt. to stay home from school.
Acute Symptoms began in August of 2023.  They were/are as follows:  extreme lethargy, light-headedness, dizzy, presyncope, syncope, sensitivity to sounds, sensitivity to light, headaches, nausea, brain fog, inability to tolerate position changes, constipation, joint pain, and and generally unwell. Patient's extreme fluctuations in blood pressure and significant rise of heart rate is present any time his head is elevated above his heart.  Therefore, making sitting, standing, or walking more than a few minutes near impossible.  He is not able to perform daily activities of living and therefore can not attend school or sports.  Total duration to date is almost two months, with no improvement.  More testing and time will determine if this Dysautonomia Patient is enduring will be a life long chronic condition, or a single acute episode.
Large red area with prominent swelling, appearing 1 week after vaccine administration.  Warm to touch and itching.
Rash 57 hours after, rash with hives 59 hours after, swelling of face and diffuse rash and hives, hypotension and uvula swelling 70 hours after
c/o headache-   IDDM- ate breakfast 0930 other and nothing since.   Denies any of adverse symptoms.   does self report. high anxiety R/T being here, getting vaccine & "emtional" as has not seen spouse who underwent liver transplant 2 months ago & contracted meningitis.  173/94- 72 given water & banana.  Rested & relaxed w/ fresh air flow x 15 additional mins. w/ resolution of symptoms.
Patient arrived for 2nd dose. It was not noted that he arrived one week early for his second dose. His first dose had been administered while he was inpatient at the local hospital. His second dose was due 8/9 and it was administered today in error.
Experienced mild covid symptoms, on 10/24/2022. Tested at home. Positive result 10/26/2022. Prescribed /started paxlovid on 10/26/2022 for 5 days. Symptoms began to resolve on 10/29/2022. Tested negative at home on 10/31/2022.
Headaches; migraines; Light and noise sensitivity.; noise sensitivity; This is a spontaneous report from a contactable consumer or other non hcp. A 43-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 02Mar2021 05:15 (Batch/Lot Number: EL9269) as single dose for covid-19 immunisation. Medical history included hashimotos thyroid, drug hypersensitivity, food allergy unknown if ongoing, drug hypersensitivity from unknown if ongoing, allergies to medications, food, or other products Cipro, doxycycline. Concomitant medication(s) included sertraline hcl (ZOLOFT) taken for an unspecified indication, start and stop date were not reported; alprazolam (ALPRAZOLAM) taken for an unspecified indication, start and stop date were not reported. On 09Feb2021 the patient experienced headaches, migraines, light and noise sensitivity, noise sensitivity. The outcome of the events was not recovered.